Found 489 hits.
|
458. |
Marcelino, J.+*, Baumann, K.*, Skov, P. S., Pereira Santos, M. C., Wyroslak, I., Scheffel, J., Altrichter, S., Woetmann, A., Pereira-Barbosa, M., Costa, C., and Maurer, M.+: What basophil testing tells us about CSU patients – results of the CORSA study. Front Immunol. 2021: 12; 742470. IF: 8.79 |
o.458
| 288 | Ohanyan, T., Schoepke, N., Bolukbasi, B., Metz, M., Hawro, T., Zuberbier, T., Peveling-Oberhag, A., Staubach, P., Maurer, M. and Weller, K.+: Responsiveness and minimal important difference of the urticaria control test (UCT). J. Allergy Clin. Immunol. 2017: 140; 1710-1713. IF: 13.26 |
| 25 | Cindik, E. D.+, Maurer, M. Hannan, M. K., Müller, R., Hayes, W. C., Hovy, L., and Kurth, A.: Phenotypical characterization of c-kit receptor deficient mouse femurs using non-destructive high-resolution imaging techniques and biomechanical testing. Technol. Health Care 2000: 8; 267-275. IF: N/A |
o.025
|
547. |
Moñino-Romero, S., Hackler, Y., Okas, T.-L., Grekowitz, E. M., Fluhr, J. W., Hultsch, V., Kiefer, L. A., Pyatilova, P., Terhorst-Molawi, D., Xiang, Y.-K., Siebenhaar, F., Maurer, M., and Kolkhir, P.+: Positive basophil tests are linked to high disease activity and other features of autoimmune chronic spontaneous urticaria: a systematic review. J. Allergy Clin. Immunol. Pract. 2023: 11; 2411-2416. IF: 8.20 |
o.547
|
548. |
Fijen, L. M.+, Vera, C., Buttgereit, T., Bonnekoh, H., Maurer, M., Magerl, M., and Weller, K.: Sensitivity to change and minimal clinically important difference of the angioedema control test. Clin. Transl. Allergy 2023: 13; e12295. IF: 4.60 |
o.548
| 33 | Peters, E. M., Maurer, M. Botchkarev, V. A., deMasey Jensen, K., Welker, P., Scott, G. A., and Paus, R.+: Kit is expressed by epithelial cells in vivo. J. Invest. Dermatol. 2003: 121; 976-984. IF: 4.19 |
| 57 | Magerl, M., Schmolke, J, Siebenhaar, F., Zuberbier, T., Metz, M., and Maurer, M.+: Acquired cold urticaria symptoms can be safely prevented by Ebastine. Allergy 2007: 62; 1465-1468. IF: 5.01 |
| 33. | Maurer, M.: Cold urticaria: a management model for difficult-to-treat chronic urticaria. Ann. Dermatol. Vener. 2009: 136; 15-18. IF: 0.39 |
| 370 | Scheffel, J., Mahnke, N. A., Hofman, Z. L. M., de Maat, S., Wu, J., Bonnekoh, H., Pengelly, R. J., Ennis, S., Holloway, J. W., Church, M. K., Maurer, M., Maas, C., and Krause, K.: Cold-induced urticarial autoinflammatory syndrome related to factor XII activation. Nat. Commun. 2020: 11; 179. IF: 14.92 |
o.370
|
549. |
Cohn, D. M.+, Aygören-Pürsün, E., Bernstein, J. A., Farkas, SH., Lumry, W. R., Maurer, M., Zanichelli, A., Iverson, M., Hao, J., Smith, M. D., Yea, C. M., Audhya, P. K., and Riedl, M. A.: Evaluation of patient-reported outcome measures for on-demand treatment of hereditary angioedema attacks and design of KONFIDENT, a phase 3 trial of Sebetralstat. Clin. Transl. Allergy 2023: 23; e12288. IF: 4.60 |
o.549